Onyx Pharmaceuticals, Inc. (ONXX), Amgen, Inc. (AMGN), Alexion Pharmaceuticals, Inc. (ALXN): Biotech’s Falling Fortunes Stymie Osiris Therapeutics, Inc. (OSIR)’s Huge Week

Page 2 of 2

Considering how prevalent diabetes is and how much it’s growing — the International Diabetes Federation expects the worldwide diabetes population to grow to 552 million patients by 2030 — any advance in this area for Grafix and Osiris Therapeutics, Inc. (NASDAQ:OSIR) is a welcome one by investors.

The article Biotech’s Falling Fortunes Stymie Osiris’ Huge Week originally appeared on Fool.com and is written by Dan Carroll.

Fool contributor Dan Carroll and The Motley Fool have no position in any of the stocks mentioned.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Page 2 of 2